J Pers Med. 2021 Feb 19;11(2). doi: 10.3390/jpm11020148.

A Prospective Study: Highlights of Hippocampal Spectroscopy in Cognitive Impairment in Patients with Type 1 and Type 2 Diabetes.

Journal of personalized medicine

Julia Samoilova, Mariia Matveeva, Olga Tonkih, Dmitry Kudlau, Oxana Oleynik, Aleksandr Kanev

PMID: 33669655 PMCID: PMC7922999 DOI: 10.3390/jpm11020148

Abstract

Diabetes mellitus type 1 and 2 is associated with cognitive impairment. Previous studies have reported a relationship between changes in cerebral metabolite levels and the variability of glycemia. However, the specific risk factors that affect the metabolic changes associated with type 1 and type 2 diabetes in cognitive dysfunction remain uncertain. The aim of the study was to evaluate the specificity of hippocampal spectroscopy in type 1 and type 2 diabetes and cognitive dysfunction.

MATERIALS AND METHODS: 65 patients with type 1 diabetes with cognitive deficits and 20 patients without, 75 patients with type 2 diabetes with cognitive deficits and 20 patients without have participated in the study. The general clinical analysis and evaluation of risk factors of cognitive impairment were carried out. Neuropsychological testing included the Montreal Scale of Cognitive Dysfunction Assessment (MoCA test). Magnetic resonance spectroscopy (MRS) was performed in the hippocampal area, with the assessment of

RESULTS: Changes in the content of NAA, choline Cho, phosphocreatine Cr2 and their ratios were observed in type 1 diabetes. More pronounced changes in hippocampal metabolism were observed in type 2 diabetes for all of the studied metabolites. Primary risk factors of neurometabolic changes in patients with type 1 diabetes were episodes of severe hypoglycemia in the history of the disease, diabetic ketoacidosis (DKA), chronic hyperglycemia, and increased body mass index (BMI). In type 2 diabetes, arterial hypertension (AH), BMI, and patient's age are of greater importance, while the level of glycated hemoglobin (HbA1c), duration of the disease, level of education and insulin therapy are of lesser importance.

CONCLUSION: Patients with diabetes have altered hippocampal metabolism, which may serve as an early predictive marker. The main modifiable factors have been identified, correction of which may slow down the progression of cognitive dysfunction.

Keywords: cognitive dysfunction; hippocampus; proton spectroscopy; type 1 diabetes mellitus; type 2 diabetes mellitus

References

1. NMR Biomed. 2004 Oct;17(6):405-10 - PubMed
2. Future Neurol. 2014 May 1;9(3):341-354 - PubMed
3. Magn Reson Imaging. 2014 Oct;32(8):1037-42 - PubMed
4. Diabetes Care. 2014;37(1):9-16 - PubMed
5. Psychosom Med. 2015 Jul-Aug;77(6):616-21 - PubMed
6. Nat Rev Neurosci. 2015 Nov;16(11):660-71 - PubMed
7. Radiology. 1992 Jul;184(1):123-30 - PubMed
8. Neurology. 2000 Jul 25;55(2):210-7 - PubMed
9. Diabetes. 2016 Jun;65(6):1601-5 - PubMed
10. Molecules. 2020 Nov 17;25(22): - PubMed
11. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(3):19-22 - PubMed
12. J Diabetes Complications. 2019 Apr;33(4):323-328 - PubMed
13. Neurobiol Aging. 2014 Jul;35(7):1660-8 - PubMed
14. Biosci Rep. 2018 Sep 7;38(5): - PubMed
15. J Cereb Blood Flow Metab. 2015 Nov;35(11):1738-45 - PubMed
16. J Am Geriatr Soc. 2020 Feb;68(2):444-445 - PubMed
17. Front Neurol. 2019 Nov 12;10:1068 - PubMed
18. Int J Pharma Bio Sci. 2014 Oct;5(4):1118-1123 - PubMed
19. J Alzheimers Dis. 2016 May 6;53(1):185-95 - PubMed
20. Neurochem Res. 2015 Dec;40(12):2647-85 - PubMed
21. Lancet Neurol. 2008 Feb;7(2):184-90 - PubMed

Publication Types

• Journal Article

Grant support

• 075-15-2020-192/Council on grants of the President of the Russian Federation